panzyga solution
octapharma pharmazeutika produktionsges m b h - immunoglobulin (human) - solution - 100mg - immunoglobulin (human) 100mg - serums
fibryga powder for solution
octapharma pharmazeutika produktionsges m b h - fibrinogen (human) - powder for solution - 1g - fibrinogen (human) 1g - hemostatics
octagam immune globulin (human)- immune globulin solution
octapharma pharmazeutika produktionsgesellschaft m.b.h. - human immunoglobulin g (unii: 66y330cjhs) (human immunoglobulin g - unii:66y330cjhs) - human immunoglobulin g 50 mg in 1 ml - octagam is an immune globulin intravenous (human) 5% liquid indicated for treatment of primary humoral immunodeficiency (pi), such as congenital agammaglobulinemia, common variable immunodeficiency, x-linked agammaglobulinemia, wiskott-aldrich syndrome and severe combined immunodeficiencies. octagam 5% liquid is contraindicated in patients who have acute severe hypersensitivity reactions to human immunoglobulin. octagam 5% liquid contains trace amounts of iga (not more than 0.2 mg/ml in a 5% solution). it is contraindicated in iga deficient patients with antibodies against iga and history of hypersensitivity (see description [11]). octagam 5% liquid is contraindicated in patients with acute hypersensitivity reaction to corn. octagam 5% liquid contains maltose, a disaccharide sugar which is derived from corn. patients known to have corn allergies should avoid using octagam 5% liquid. pregnancy category c. animal reproduction studies have not been conducted with octagam 5% liquid. it is also not known whether o
wilate - von willebrand factor/coagulation factor viii complex (human) (von willebrand factor/coagulation factor viii complex- h
octapharma pharmazeutika produktionsgesellschaft m.b.h. - antihemophilic factor human (unii: 839moz74gk) (antihemophilic factor human - unii:839moz74gk), von willebrand factor human (unii: ze22ne22f1) (von willebrand factor human - unii:ze22ne22f1) - antihemophilic factor human 100 [iu] in 1 ml - wilate is a von willebrand factor/coagulation factor viii complex (human) indicated for the treatment of spontaneous and trauma-induced bleeding episodes in patients with severe von willebrand disease (vwd) as well as patients with mild or moderate vwd in whom the use of desmopressin is known or suspected to be ineffective or contraindicated. clinical trials to evaluate the safety and efficacy of prophylactic dosing with wilate to prevent spontaneous bleeding have not been conducted in vwd subjects. wilate is not indicated for the prevention of excessive bleeding during and after surgery in vwd patients. wilate is not indicated for hemophilia a. wilate is contraindicated for patients who have known anaphylactic or severe systemic reaction to plasma-derived products, any ingredient in the formulation, or components of the container. for a complete listing of ingredients, see description ( 11 ). pregnancy category c. animal reproduction studies have not been conducted with wilate. it is also not known whether
scanlux 370mg i/ml 755mg/ml (370mg i/ml) solution for injection
sanochemia pharmazeutika ag - iopamidol - solution for injection - 755mg/ml (370mg i/ml)
scanlux 300mg i/ml 612mg/ml (300mg i/ml) solution for injection
sanochemia pharmazeutika ag - iopamidol - solution for injection - 612mg/ml (300mg i/ml)
nuwiq kit
octapharma pharmazeutika produktionsges m b h - simoctocog alfa; water - kit - 250unit; 2.5ml - simoctocog alfa 250unit; water 2.5ml - hemostatics
nuwiq kit
octapharma pharmazeutika produktionsges m b h - simoctocog alfa; water - kit - 500unit; 2.5ml - simoctocog alfa 500unit; water 2.5ml - hemostatics
nuwiq kit
octapharma pharmazeutika produktionsges m b h - simoctocog alfa; water - kit - 1000unit; 2.5ml - simoctocog alfa 1000unit; water 2.5ml - hemostatics
nuwiq kit
octapharma pharmazeutika produktionsges m b h - simoctocog alfa; water - kit - 2000unit; 2.5ml - simoctocog alfa 2000unit; water 2.5ml - hemostatics